Clinical Trials Sponsored by VERTEX Pharmaceutical
Total 19911 results
-
Chugai PharmaceuticalCompleted
-
Chugai PharmaceuticalCompleted
-
Chugai PharmaceuticalCompletedChemotherapy Induced Anemia
-
Chugai PharmaceuticalCompletedRheumatoid Arthritis
-
Chugai PharmaceuticalCompletedHemodialysis PatientsJapan
-
Zeria PharmaceuticalCompleted
-
Chugai PharmaceuticalCompleted
-
Chugai PharmaceuticalCompleted
-
Jacobus PharmaceuticalTerminatedCrohn's DiseaseUnited States, Israel
-
BioMarin PharmaceuticalApproved for marketing
-
Kaken PharmaceuticalCompleted
-
BioMarin PharmaceuticalCompletedPhenylketonuriasUnited States
-
Xintian PharmaceuticalNot yet recruiting
-
BioMarin PharmaceuticalNot yet recruitingIdiopathic Short Stature
-
BioMarin PharmaceuticalRecruitingDuchenne Muscular DystrophySpain, Turkey, United Kingdom, Italy
-
BioMarin PharmaceuticalRecruitingHypochondroplasiaUnited States, Spain, Canada, France, Japan, Australia, Italy, Argentina, Brazil, Germany, United Kingdom
-
Chugai PharmaceuticalRecruitingSolid TumorUnited States, Japan
-
BioMarin PharmaceuticalRecruiting
-
Zeria PharmaceuticalRecruitingFunctional DyspepsiaJapan
-
JW PharmaceuticalRecruitingHypercholesterolemiaKorea, Republic of
-
BioMarin PharmaceuticalActive, not recruitingPhenylketonuria (PKU)United States, Germany
-
BioMarin PharmaceuticalCompletedAchondroplasiaUnited States, Australia, United Kingdom, Japan
-
BioMarin PharmaceuticalWithdrawnNonalcoholic Fatty Liver Disease | Kidney Stone | HyperoxaluriaUnited States
-
BioMarin PharmaceuticalActive, not recruitingHereditary Angioedema | HAESpain, United States, Australia
-
BioMarin PharmaceuticalActive, not recruiting
-
JW PharmaceuticalCompleted
-
BioMarin PharmaceuticalActive, not recruitingLate-Infantile Neuronal Ceroid Lipofuscinosis Type 2United States
-
BioMarin PharmaceuticalActive, not recruitingHemophilia AUnited States, Taiwan, United Kingdom, Australia, Israel, Belgium, Brazil, France, Germany, Italy, Korea, Republic of, South Africa, Spain
-
BioMarin PharmaceuticalActive, not recruiting
-
BioMarin PharmaceuticalActive, not recruitingAchondroplasiaUnited States, Australia, Germany, Spain, United Kingdom, Japan, Turkey
-
BioMarin PharmaceuticalActive, not recruitingAchondroplasiaUnited States, Australia, France, United Kingdom
-
Chugai PharmaceuticalCompleted
-
BioMarin PharmaceuticalTerminatedAchondroplasiaUnited States
-
Allysta PharmaceuticalCompletedDry Eye DiseaseUnited States
-
BioMarin PharmaceuticalCompleted
-
BioMarin PharmaceuticalCompletedBatten Disease | CLN2 Disease | Late-Infantile Neuronal Ceroid Lipofuscinosis Type 2 | Jansky-Bielschowsky Disease | CLN2 DisorderUnited States, Germany, Italy, United Kingdom
-
BioMarin PharmaceuticalTerminatedLate-onset Pompe DiseaseUnited States, United Kingdom
-
JW PharmaceuticalCompletedHealthy, Renal ImpairmentKorea, Republic of
-
BioMarin PharmaceuticalCompletedPhenylketonuria | HyperphenylalaninaemiaUnited States
-
BioMarin PharmaceuticalCompletedBatten Disease | CLN2 Disease | Late-Infantile Neuronal Ceroid Lipofuscinosis Type 2 | Jansky-Bielschowsky Disease | CLN2 DisorderUnited States, Germany, Italy, United Kingdom
-
Bukwang PharmaceuticalCompletedGastric CancerKorea, Republic of
-
JW PharmaceuticalCompleted
-
BioMarin PharmaceuticalCompletedPhenylketonuria (PKU)United States
-
BioMarin PharmaceuticalCompletedPhenylketonuriaUnited States
-
Chugai PharmaceuticalTerminatedHypoparathyroidismUnited States, Canada, Hungary
-
BioMarin PharmaceuticalCompletedPhenylketonuria (PKU)United States
-
BioMarin PharmaceuticalCompletedEndothelial DysfunctionUnited States
-
JW PharmaceuticalActive, not recruitingType 2 Diabetes MellitusKorea, Republic of
-
Zeria PharmaceuticalCompleted
-
JW PharmaceuticalCompletedType 2 DiabetesKorea, Republic of